- Breakthrough in fight against world’s deadliest cancer – new drug shrunk up to 70% of pancreatic tumors in lab Daily Mail
- Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy Nature.com
- Novel Treatment Options for Pancreatic Tumors Unlocked Genetic Engineering & Biotechnology News
- Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins Yahoo Finance
- Investigational therapeutic shows promise in preclinical pancreatic cancer model Medical Xpress
Read More: Breakthrough in fight against world’s deadliest cancer – new drug shrunk up to